Nachricht des Unternehmens vom 30.04.2020 6:00am EDTCytoDyn Reports
Strong Results from eIND COVID-19 Patients Treated with Leronlimab;
Majority of Patients Have Demonstrated Remarkable Recoveries
https://www.cytodyn.com/newsroom/press-releases Einfa...
